Specijalna bolnica Medico
Rijeka 51000
5 studies enrolling now · 7 studies all time
What they study most
Advanced Non-Small Cell Lung Cancer, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Heart Failure, Hypertension, Metastatic Non-Small Cell Lung Cancer, Proteinuric Kidney Diseases, Systemic Lupus Erythematosus, Systemic Sclerosis
Studies at this site
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
- PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease — Recruiting now
- A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE) — Recruiting now
- A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis — Recruiting now
- Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
- A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
- Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes — Withdrawn before enrolling